SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005900
Filing Date
2024-02-12
Accepted
2024-02-12 16:15:28
Documents
16
Period of Report
2024-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43293
2 ex99-1.htm EX-99.1 19400
  Complete submission text file 0001493152-24-005900.txt   288778

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20240212.xsd EX-101.SCH 3872
4 XBRL DEFINITION FILE celu-20240212_def.xml EX-101.DEF 26769
5 XBRL LABEL FILE celu-20240212_lab.xml EX-101.LAB 37009
6 XBRL PRESENTATION FILE celu-20240212_pre.xml EX-101.PRE 25393
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5915
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24620083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)